Toggle light / dark theme

Alopecia refers to hair loss and can affect the scalp, eyebrows, eyelashes, and other areas of the body. There are different types of alopecia including androgenetic alopecia, alopecia areata, anagen effluvium, and frontal fibrosing alopecia (FFA). Each form of disease refers to where and how hair is lost. This type of categorization helps physicians best diagnose and treat patients. Frontal fibrosing alopecia was first recognized in the early 1990s and still puzzles scientists and physicians. It is characterized by progressive loss with hair follicles becoming inflamed and destroyed. Eyebrow thinning is also a common symptom along with skin redness and scaling, and wrinkling.

Unfortunately, the cause of FFA is unknown and is a type of scarring hair loss, which means that the hair cannot grow back. This particularly distressing condition is thought to be the result of an autoimmune disorder. Many scientists believe FFA is caused by hormonal imbalances or genetic predispositions. Scientists are currently trying to find ways to cure or permanently treat FFA. Treatment options to date include topical corticosteroids, oral medication, light therapy, and hair transplantation. However, all of these treatments work to relieve symptoms, delay hair loss, or replace hair loss. Since FFA is a chronic condition, symptoms can progress over time and with early intervention, patients can significantly delay hair loss. The lack of sufficient treatment is still a concern, and many researchers are investigating how to overcome this disease and avoid hair loss.

A recent paper in JAMA Dermatology, by Dr. Christos Tziotzios and others, reported a change in two areas of the human genome that can influence alopecia risk. This is a major advance in the field of alopecia and can be used to enhance treatment. Tziotzios is a Consultant Dermatologist and Senior Lecturer at St. John’s Institute of Dermatology in the United Kingdom (UK). He specializes in general dermatology and hair and scalp disorders including FFA in both biological males and females.

Only weeks after Figure.ai announced ending its collaboration deal with OpenAI, the Silicon Valley startup has announced Helix – a commercial-ready, AI “hive-mind” humanoid robot that can do almost anything you tell it to.

Figure has made headlines in the past with its Figure 01 humanoid robot. The company is now on version 2 of its premiere robot, however, it’s received more than just a few design changes: it’s been given an entirely new AI brain called Helix VLA.

It’s not just any ordinary AI either. Helix is the very first of its kind to be put into a humanoid robot. It’s a generalist Vision-Language-Action model. The keyword being “generalist.” It can see the world around it, understand natural language, interact with the real world, and it can learn anything.

A new breakthrough in cosmic mapping has unveiled the structure of a colossal filament, part of the vast cosmic web that connects galaxies.

Dark matter and gas shape these filaments, but their faint glow makes them hard to detect. By using advanced telescope technology and hundreds of hours of observation, astronomers have captured the most detailed image yet, bringing us closer to decoding the evolution of galaxies and the hidden forces shaping the universe.

The hidden order of the universe.

Science and Technology: Gene Therapy apparently Cure Blindness in Children.

S eye, very early in life, to treat a severe form of the condition.‘.


An experimental trial of gene therapy has helped four toddlers — born with one of the most severe forms of childhood blindness — gain “life-changing improvements” to their sight, according to doctors at Moorfields Eye Hospital in London.

The rare genetic condition means the babies’ vision deteriorated very rapidly from birth.

He emphasized that enhancing intelligence models is key to Alibaba’s long-term vision as it shifts towards AI technologies.

This aligns with Alibaba’s declaration as an AI-driven company.

While e-commerce remains central, Alibaba’s cloud services saw strong growth, with revenue rising 13% last quarter. AI-related products within the cloud division posted triple-digit growth.

Introduces the first World and Human Action Model (WHAM). The WHAM, which we’ve named “Muse,” is a generative AI model of a video game that can generate game visuals, controller actions, or both.


Today Nature published Microsoft’s research detailing our WHAM, an AI model that generates video game visuals & controller actions. We are releasing the model weights, sample data, & WHAM Demonstrator on Azure AI Foundry, enabling researchers to build on the work.